TGFB1 and fibrosis: Specifically, the CM were statistically significant in decreasing the TGF-β-induced migration rate (TGF-β + 83 μg/mL CM: 95.28% IQR: 61.48–113.80, p < 0.001 and TGF-β + 830 μg/mL CM: 88.28% IQR: 49.04–113.60, p < 0.0001; Figure 8B), suggesting that the CM could have a therapeutic effect on fibrosis, as they could halt the TGF-β-induced migration rate of hPSMs.